MedPath

Exercise Training in Adults With Corrected Tetralogy of Fallot

Not Applicable
Completed
Conditions
Tetralogy of Fallot
Interventions
Other: Exercise training
Registration Number
NCT02643810
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

In this controlled trial, patients with tetralogy of Fallot will be randomized to either interval training, continuous training, or usual care groups.

Detailed Description

Patients after surgical correction of tetralogy of Fallot (cTF) have impaired exercise tolerance as compared to healthy age-matched individuals. In this controlled trial, patients with cTF will be randomized to either interval training, continuous training, or usual care.

The aim of the study is to compare the effect of interval vs. continuous exercise training on:

i) exercise capacity ii) vascular function iii) arrhythmogenic potential iv) parameters of inflammation, hemostasis and heart failure severity v) health-related quality of life adults with cTF

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • congenital tetralogy of Fallot surgically corrected in childhood
Exclusion Criteria
  • contraindications for exercise training,
  • uncontrolled dysrhythmias,
  • uncontrolled heart failure (New York Heart Association (NYHA) stage IV),
  • unstable coronary or other arterial disease,
  • intellectual development disorder,
  • pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interval training groupExercise trainingPatients to be randomized to the 'interval training group' will have exercise training sessions 3 times per week for a period of 12 weeks. During training, they will undergo interval exercise series composed of high-intensity intervals (80-90% of peak heart rate) and low-intensity intervals (50-70% of peak heart rate).
Continuous training groupExercise trainingPatients to be randomized to the 'continuous training group' will have exercise training sessions 3 times per week for a period of 12 weeks. They will undergo moderate continuous exercise training at 70-75% of peak heart rate.
Primary Outcome Measures
NameTimeMethod
Change of maximal oxygen uptake during exercise, measured in ml/kg/min3 months
Secondary Outcome Measures
NameTimeMethod
Change of the value of blood fibrinogen, measured in g/l3 months
Change of the ECG waves3 months

Estimated with digital high-resolution ECG

Change in the result of the 6-minute walking test, measured in metres3 months
Change of flow-mediated dilatation of the brachial artery, measured in %3 months

Flow-mediated dilation (FMD) and arterial stiffness

Change of the value of blood N terminal-proBNP, measured in ng/l3 months
Change of the value of blood D-dimer, measured in microg/l3 months
Change of from-the-questionnaire-obtained quality of life, measured in points3 months
Change of the heart rate variability3 months

Estimated with digital high-resolution ECG

Change of the arterial stiffness coefficient3 months

Trial Locations

Locations (1)

University Medical Centre Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath